科创成长层新消息：禾元生物启动发行

Core Viewpoint - The launch of Wuhan Heyuan Biotechnology Co., Ltd.'s IPO marks a significant step in the "1+6" reform of the Sci-Tech Innovation Board, indicating progress in the establishment of the Sci-Tech Growth Layer [1] Group 1: Reform Progress - The IPO process for the first batch of newly registered companies in the Sci-Tech Growth Layer is being carried out in an orderly manner [1] - Securities firms are organizing investors to sign risk disclosure agreements for participating in the Sci-Tech Growth Layer trading [1] Group 2: Investor Engagement - Approximately 5 million investors have opened trading permissions for the Sci-Tech Growth Layer [1] - The Shanghai Stock Exchange's technical system has completed network testing and is gradually going live [1] Group 3: Market Readiness - The issuance preparations for newly registered companies in the Sci-Tech Growth Layer are ready [1]